Marc Hartmann

Showing 1-9 of 9 articles

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

Kok M, Zocca P, Buiten R, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Stoel M, van Houwelingen K, Linssen GCM, Doggen CJM, von Birgelen C

October 19, 2018 | 10.4244/EIJ-D-18-00336

Stents and scaffolds

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population

Kok M, von Birgelen C, Sattar N, Zocca P, Löwik M, Danse PW, Schotborgh CE, Scholte M, Hartmann M, Kant GD, Doelman CJA, Gin M, Stoel M, van Houwelingen K, Linssen GCM, IJzerman M, Doggen CJM, van der Heijden LC

October 12, 2018 | 10.4244/EIJ-D-17-01067

Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT

Zocca P, van der Heijden LC, Kok M, Löwik M, Hartmann M, Stoel M, Louwerenburg H, de Man F, Linssen GCM, Knottnerus I, Doggen CJM, van Houwelingen K, von Birgelen C

November 20, 2017 | 10.4244/EIJ-D-17-00634

Coronary interventions

Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial

van der Heijden LC, Kok M, Löwik M, Danse PW, Jessurun G, Hautvast R, van Houwelingen K, Stoel M, Hartmann M, Linssen GCM, Doggen CJM, von Birgelen C

April 20, 2017 | 10.4244/EIJ-D-16-00571

Coronary interventions

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

Kok M, von Birgelen C, Lam MK, Löwik M, van Houwelingen K, Stoel M, Louwerenburg H, de Man F, Hartmann M, Doggen CJM, van Til J, IJzerman M

April 20, 2016 | 10.4244/EIJY15M10_06

Giant coronary aneurysm in Churg-Strauss syndrome

Hartmann M, Wajon E, van Houwelingen K, Stoel M, von Birgelen C

October 26, 2012 | 10.4244/EIJV8I6A116

Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry

de Man F, Tandjung K, Hartmann M, van Houwelingen K, Stoel M, Louwerenburg H, Basalus M, Sen H, Löwik M, von Birgelen C

July 27, 2012 | 10.4244/EIJV8I3A52

Beyond the lumen border: on the use of intravascular ultrasound in the left main coronary artery

von Birgelen C, Hartmann M

July 29, 2011 | 10.4244/EIJV7I3A52

Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-tomoderate coronary atherosclerosis: an international multicentre study

Huisman J, Egede R, Rdzanek A, Böse D, Erbel R, Kochman J, Okkels Jensen L, Van de Palen J, Hartmann M, Mintz G, von Birgelen C

April 12, 2010

1

Latest news

TAVI dysfunction, coronary sinus narrowing, carotid interventions through the snuffbox, and more

CT image showing a case of valve thrombosis after ViV TAVI

February 20, 2020

Will Your Heart Team EXCEL?

February 20, 2020

This Weeks JAA's: SAFE-A study, Coronary access after TAVR-in-TAVR and much more

February 25, 2020

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

New ahead of print: Validation of ARC-HBR criteria

February 18, 2020

New Editor-in-Chief editorial: Moving forward

Davide Capodanno

February 7, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke